It was reported that, during treatment of a chest tube wound with an unknown opsite post op dressing, a patient indicated that the dressing did not provide prevention against wound maceration; therefore, it was needed an additional foam dressing underneath to better absorb exudate.As this was noticed in a retrospective post market clinical follow up activity, further information is not available.
|
H10: the complaint was received as a result of issues being identified in a post market clinical survey.Due to this, no specific product details or batch/lot numbers have been available to the investigation.As a result of this, no device history review was possible.A complaint history review was performed for the product family and event description, there have been further instances in the past three years.According to the survey, the devices were being used in patient treatment.The devices used for treatment have not been returned to smith and nephew for analysis.We have therefore not been able to confirm a relationship between the event and the device or identify a definitive root cause.As no further information is available, it is not possible to establish a link between the product and harm within this complaint.No relevant supporting clinical information has been provided to assist with a clinical investigation.The patient's current condition is unknown and the patient impact beyond the reported events could not be determined based on the limited information provided.Therefore, based on insufficient information, a thorough clinical assessment cannot be performed at this time.Should any additional clinical information be provided this complaint will be re-evaluated.Users of the device are advised to consult the instructions for use, to reduce future occurrences of the reported issue.This guide provides comprehensive instructions of the operation, use and limitations of the device, including advice on application and removal of dressings.This investigation has now been closed.No further actions by smith and nephew are deemed necessary at this stage.We will continue to monitor for any adverse trends relating to all product ranges.
|